ComPsych Boasts Industry's Most Comprehensive Library of Dynamic Mental Health Resources
CHICAGO--(BUSINESS WIRE)-- ComPsych ® Corporation, the worldwide leader in organizational mental health, well-being, and absence management, now boasts the industry's most comprehensive, dynamic library of mental health resources, allowing GuidanceResources users to access information in a variety of formats, languages, dialects, and mediums. This wide-ranging library complements ComPsych's vast network of more than 120,000 therapists, counselors, and coaches around the world, empowering users to explore self-guided resources across six key pillars of well-being: mental, emotional, physical, social, legal, and financial.
By transforming our resource library and investing in global parity, we're empowering users worldwide on their unique well-being journeys.
Share
'In today's global and multigenerational workforce, it's essential that we meet users where they are,' said ComPsych CEO Paul Posey. 'In addition to connecting users with talented counselors and coaches, we're also proud to provide engaging content that can be consumed however is most convenient and useful for people. By transforming our resource library and investing in global parity, we're empowering users worldwide on their unique well-being journeys.'
Following the rollout of the reimagined digital experience in GuidanceResources Online on Jan. 1, 2025, ComPsych has tripled the amount of dynamic video assets available on the platform, with videos available in nearly 40 languages. Most recently, ComPsych implemented an AI-powered audio reader allowing users to listen to any text-based resources, including at increased or half speed based on their preference. The audio reader feature is currently available in multiple languages, covering 97% of ComPsych's global user base of 160 million people around the world. In total, ComPsych has increased in the amount of dynamic content available on GuidanceResources Online by 282% in the first six months of 2025.
Other enhancements to ComPsych's digital resource library include improved localized imagery for each global locale, featuring people of ethnic or racial backgrounds similar to the country or region that a member is accessing GuidanceResources Online from. This change along with the introduction of more dynamic content has resulted in increased overall usage and engagement across the platform. Globally, from May 2024 to May 2025, ComPsych saw a 38% increase in digital asset engagement.
'At ComPsych, we know everyone's well-being journey is different,' said Dr. Jennifer Birdsall, Chief Clinical Officer at ComPsych. 'Our ability to match user preferences in how they want to engage in well-being tools and content is driving utilization, including at the prevention and early intervention stages, allowing us to address concerns before they turn into something more significant. We're thrilled to see that providing more dynamic mental health resources, touching on a wide variety of topics and across a range of modalities, is increasing user engagement and ultimately building both individual and organizational resiliency and driving stronger clinical outcomes for our global population.'
For more information on how ComPsych is innovating to ignite human potential in workplaces worldwide, please visit www.compsych.com.
About ComPsych
ComPsych ® is the worldwide leader in organizational mental health, well-being, and absence management, dedicated to igniting human potential in workplaces across the globe. For over 40 years, we have combined the best in technology with unmatched human expertise to help individuals and their organizations thrive. Our GuidanceResources ® and AbsenceResources ® solutions deliver end-to-end mental health, well-being, work-life, health navigation, and absence support to more than 75,000 customers worldwide, touching more than 160 million lives across 200 countries. Visit compsych.com to find out why 40% of the Fortune 500 choose ComPsych for their mental health and absence management needs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Corning Announces Quarterly Dividend
CORNING, N.Y., June 25, 2025--(BUSINESS WIRE)--Corning Incorporated's (NYSE: GLW) Board of Directors today declared a quarterly dividend of $0.28 per share. The dividend will be payable on September 29, 2025, to shareholders of record on August 29, 2025. Caution Concerning Forward-Looking StatementsThe statements contained in this release and related comments by management that are not historical facts or information and contain words such as "will," "believe," "anticipate," "expect," "intend," "plan," "seek," "see," "would," "target," "estimate," "forecast" or similar expressions are forward-looking statements. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include estimates and assumptions related to economic, competitive and legislative developments. Such statements relate to future events that by their nature address matters that are, to different degrees, uncertain. These forward-looking statements relate to, among other things, the Company's Springboard plan, the company's future operating performance, the company's share of new and existing markets, the company's revenue and earnings growth rates, the company's ability to innovate and commercialize new products, the company's expected capital expenditure and the company's implementation of cost-reduction initiatives and measures to improve pricing, including the optimization of the company's manufacturing capacity. Although the company believes that these forward-looking statements are based upon reasonable assumptions regarding, among other things, current estimates and forecasts, general economic conditions, its knowledge of its business and key performance indicators that impact the company, there can be no assurance that these forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The company undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change except as required by applicable securities laws. Some of the risks, uncertainties and other factors that could cause actual results to differ materially from those expressed in or implied by the forward-looking statements include, but are not limited to: global economic trends, competition and geopolitical risks, or an escalation of sanctions, tariffs or other trade tensions between the U.S. and other countries, and related impacts on our businesses' global supply chains and strategies; changes in macroeconomic and market conditions and market volatility, including developments and volatility arising from health crisis events, inflation, interest rates, the value of securities and other financial assets, precious metals, oil, natural gas, raw materials and other commodity prices and exchange rates (particularly between the U.S. dollar and the Japanese yen, South Korean won, Chinese yuan, New Taiwan dollar, Mexican Peso and euro), decreases or sudden increases of consumer demand, and the impact of such changes and volatility on our financial position and businesses; the availability of or adverse changes relating to government grants, tax credits or other government incentives; the duration and severity of health crisis events, such as an epidemic or pandemic, and its impact across our businesses on demand, personnel, operations, our global supply chains and stock price; possible disruption in commercial activities or our supply chain due to terrorist activity, cyber-attack, armed conflict, political or financial instability, natural disasters, international trade disputes or major health concerns; loss of intellectual property due to theft, cyber-attack, or disruption to our information technology infrastructure; ability to enforce patents and protect intellectual property and trade secrets; disruption to Corning's, our suppliers' and manufacturers' supply chain, equipment, facilities, IT systems or operations; product demand and industry capacity; competitive products and pricing; availability and costs of critical components, materials, equipment, natural resources and utilities; new product development and commercialization; order activity and demand from major customers; the amount and timing of our cash flows and earnings and other conditions, which may affect our ability to pay our quarterly dividend at the planned level or to repurchase shares at planned levels; the amount and timing of any future dividends; the effects of acquisitions, dispositions and other similar transactions; the effect of regulatory and legal developments; ability to pace capital spending to anticipated levels of customer demand; our ability to increase margins through implementation of operational changes, pricing actions and cost reduction measures; rate of technology change; adverse litigation; product and component performance issues; retention of key personnel; customer ability to maintain profitable operations and obtain financing to fund ongoing operations and manufacturing expansions and pay receivables when due; loss of significant customers; changes in tax laws, regulations and international tax standards; the impacts of audits by taxing authorities; the potential impact of legislation, government regulations, and other government action and investigations; and other risks detailed in Corning's SEC filings. For a complete listing of risks and other factors, please reference the risk factors and forward-looking statements described in our annual reports on Form 10-K and quarterly reports on Form 10-Q. Web DisclosureIn accordance with guidance provided by the SEC regarding the use of company websites and social media channels to disclose material information, Corning Incorporated ("Corning") wishes to notify investors, media, and other interested parties that it uses its website ( to publish important information about the company, including information that may be deemed material to investors, or supplemental to information contained in this or other press releases. The list of websites and social media channels that the company uses may be updated on Corning's media and website from time to time. Corning encourages investors, media, and other interested parties to review the information Corning may publish through its website and social media channels as described above, in addition to the company's SEC filings, press releases, conference calls, and webcasts. About Corning IncorporatedCorning ( is one of the world's leading innovators in materials science, with a 170-year track record of life-changing inventions. Corning applies its unparalleled expertise in glass science, ceramic science, and optical physics along with its deep manufacturing and engineering capabilities to develop category-defining products that transform industries and enhance people's lives. Corning succeeds through sustained investment in RD&E, a unique combination of material and process innovation, and deep, trust-based relationships with customers who are global leaders in their industries. Corning's capabilities are versatile and synergistic, which allows the company to evolve to meet changing market needs, while also helping its customers capture new opportunities in dynamic industries. Today, Corning's markets include optical communications, mobile consumer electronics, display, automotive, solar, semiconductors, and life sciences. View source version on Contacts Media Relations Contact: Gabrielle Bailey(607) 684-4557baileygr@ Investor Relations Contact:Ann H.S. Nicholson(607) 974-6716nicholsoas@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
41 minutes ago
- Yahoo
Univar Solutions Announces Expansion of Partnership With Ingredion Incorporated (INGR)
Ingredion Incorporated (NYSE:INGR) is one of the . On June 18, Univar Solutions Belgium N.V. announced the expansion of a partnership between its Foodology by Univar Solutions business and Ingredion Incorporated (NYSE:INGR) for distribution in the Benelux region. Univar Solutions is a leading provider of global solutions for specialty chemicals and ingredients, while Ingredion Incorporated (NYSE:INGR) is a global provider of ingredients for the beverage and food industries. A close up of a baker stirring a bowl of flour and sugar in a bakery. According to the announcement, the distribution expansion would be effective October 1 and is expected to bring in a comprehensive list of clean label and plant-based products, including plant-based proteins, the innovative Novation® range of functional native starches, and more, in response to the rising consumer demand for sugar reduction and clean label ingredients. Ingredion Incorporated (NYSE:INGR) is a global ingredients solutions provider that transforms fruits, vegetables, grains, and other plant-based materials into value-added ingredient solutions for several markets, including food, beverage, animal nutrition, brewing, and industrial markets. The company's products are primarily derived from the processing of corn and other starch-based materials, including rice, potato, and tapioca. It operates through four segments: North America, South America, Asia-Pacific, and Europe, Middle East and Africa (EMEA). While we acknowledge the potential of INGR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Yahoo
43 minutes ago
- Yahoo
Breakthrough in Patient-Derived Stem Cells for Therapeutic Regenerative Medicine
WALTHAM, Mass., June 25, 2025--(BUSINESS WIRE)--Minerva Biotechnologies published, "The Wnt pathway induces a naïve-like subpopulation in primed stem cells, while NME7AB leads to a homogeneous naïve-like population," in the journal PLOS One, These studies shed light on the scientific controversy of whether activation of the Wnt/β-catenin pathway induces human stem cell pluripotency or differentiation. The literature is replete with contradictory conclusions, based on what appear to be sound scientific studies. Others reported that low levels of β-catenin skew differentiation down neuroectoderm, whereas high levels favor differentiation down mesendoderm. Recently two research groups independently found that "boosting" β-catenin just prior to differentiation improved differentiation of both neuroectoderm and mesendoderm. Unexpectedly, our studies found that, in the absence of other growth factors, activation of the Wnt/β-catenin pathway induced two segregated populations: islands of naïve OCT4+ XaXa cells (both X chromosomes active) in a sea of differentiating OCT4- XaXi cells (one X chromosome inactivated). Like others, we found that activating the β-catenin pathway before or at the initiation of differentiation greatly improved the differentiation of primed state stem cells but had no effect on NME7 AB naïve state stem cells. The differentiation of homogeneous populations of NME7 AB induced naïve state stem cells was superior to that of primed state stem cells, even if the β-catenin pathway was activated before differentiation. For example, induced pluripotent stem cells (iPSC) generated in, then expanded in GMP compliant minimal media containing recombinant NME7AB as the only growth factor, differentiated with high efficiency into mesenchymal stem cells (MSCs). Unlike other attempts, Minerva's iPSC-derived MSCs resisted senescing and each clone could differentiate into essentially pure populations of chondrocytes, osteoblasts or adipocytes that could be useful for repair or replacement of cartilage, bone or fat. "These data represent a major breakthrough for the large-scale, GMP compliant manufacture of patient-derived MSCs for therapeutic uses," said Dr. Cynthia Bamdad, CEO of Minerva Biotechnologies, "and will replace the practice of using MSCs harvested from bone marrow of unknown, often untested donors." View source version on Contacts Minerva BiotechnologiesRon Axelrodraxelrod@ 617-785-9491 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
